Skip to main navigation

Client Header Links

  • About
    • Board of Directors
    • Founders
    • Leadership
    • Scientific Advisors
  • Platform
    • Technology Overview
    • Publications
  • Pipeline
    • Pipeline Overview
    • ANX005
    • ANX007
  • Investors
    • Overview
    • News Releases
    • Events and Presentations
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Shareholder Services
  • Careers
  • Contact
  • Annexon
    Biosciences

Financial Information

Investor Relations

Home
Corporate Profile
News Releases
Corporate Governance
Governance Overview
Board of Directors
Leadership
Committee Composition
SEC Filings
Contact IR

Financial Information

Investor Tools

  • Print
    Print
  • IR Contact
    IR Contact
  • RSS Feeds
    RSS Feeds
  • Email Alerts
    Email Alerts

Quick Links

Quick links

  • Pipeline
  • Platform
  • About
  • Careers
  • Privacy Policy
  • Terms of Use

stop the start of disease

Annexon Biosciences is a clinical-stage biopharmaceutical company developing novel therapies for autoimmune and neurodegenerative diseases, including opthalmic diseases.

Annexon
Biosciences

Social Media

Copyright © 2016 - 2021 Annexon Inc..
All rights reserved.